Insider Transactions Reported by 10 Insiders of Vivos Therapeutics, Inc.

Symbol
VVOS on Nasdaq
Location
Littleton, CO

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

Vivos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael C. Skaff 10%+ Owner $3,342,820 09 Jun 2025
Gurdev Dave Singh Chief Medical Officer, Director, 10%+ Owner $1,728,844 05 Aug 2021
Ronald Kirk Huntsman Chief Executive Officer, Director $1,001,675 26 Nov 2024
Bradford K. Amman Chief Financial Officer $476,649 26 Nov 2024
Leonard J. Sokolow Director $17,771 20 Jun 2024
Ralph Elias Green Director $16,819 20 Jun 2024
Mark F. Lindsay Director $16,819 20 Jun 2024
Anja B. Krammer Director $16,819 20 Jun 2024
Matthew Thompson Director $16,819 20 Jun 2024
Gregg C.E. Johnson Director $8,873 04 Feb 2026

Recent Insider Transactions by Companies or Individuals for Vivos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.